How GLP-1 supports metabolic health
Source data Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made
A portion of these costs may be eligible for coverage through Technical and Business Assistance (TABA) funding requested as part of your SBIR/STTR award
discontinuation rate 4.3-7.1% Clinical Significance: SURMOUNT-1 demonstrated weight loss comparable to bariatric surgery, representing a paradigm shift in obesity pharmacotherapy
28,36 Theoretically, the substitution of Gly 22 with Ala would make the -helix more stable, but increments in the affinity and activity were not found
A New Era for Treating Sleep Apnea